Arnold Reynaldi

Development of an mRNA-lipid nanoparticle vaccine against Lyme disease

Single immunizations of self-amplifying or non-replicating mRNA-LNP vaccines control HPV-associated tumors in mice

Durability of Vaccine-Induced and Natural Immunity Against COVID-19: A Narrative Review

Reducing cell intrinsic immunity to mRNA vaccine alters adaptive immune responses in mice

A mosquito AgTRIO mRNA vaccine contributes to immunity against malaria

The effect of COVID certificates on vaccine uptake, health outcomes, and the economy

Filgotinib suppresses HIV-1–driven gene transcription by inhibiting HIV-1 splicing and T cell activation

Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape

mRNA-LNP expressing PfCSP and Pfs25 vaccine candidates targeting infection and transmission of Plasmodium falciparum

Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study

The JAK/STAT signaling pathway: from bench to clinic

Lyophilization provides long-term stability for a lipid nanoparticle-formulated, nucleoside-modified mRNA vaccine

Defining trained immunity and its role in health and disease

Adaptation and memory in immune responses

SARS-CoV-2 mRNA Vaccines: Immunological Mechanism and Beyond

Ionizable lipid nanoparticles deliver mRNA to pancreatic β cells via macrophage-mediated gene transfer

The Impact of Evolving SARS-CoV-2 Mutations and Variants on COVID-19 Vaccines

mRNA Vaccines in the COVID-19 Pandemic and Beyond

A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes

Developmental Origin Governs CD8+ T Cell Fate Decisions during Infection

Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19

Genetically-barcoded SIV facilitates enumeration of rebound variants and estimation of reactivation rates in nonhuman primates following interruption of suppressive antiretroviral therapy

Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection